First leukaemia patient to receive pioneering treatment on NHS says it is 'very sci-fi'

The introduction of CAR-T therapy in the NHS marks a transformative step in the treatment of blood cancers. As personalized medicine continues to evolve, the implications for patient outcomes could be profound, potentially setting a precedent for future therapies. However, the accessibility and scalability of such advanced treatments will be critical in determining their long-term impact on healthcare systems.